Ka-Loh Li Selected Research

Growth Factor Receptors

12/2007

Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ka-Loh Li Research Topics

Disease

10	Neoplasms (Cancer) 10/2021 - 10/2005
4	Acoustic Neuroma (Acoustic Neurinoma) 01/2021 - 01/2014
3	Breast Neoplasms (Breast Cancer) 12/2007 - 10/2005
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2018 - 02/2016
1	Inflammation (Inflammations) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Meningioma (Meningiomas) 01/2014
1	Necrosis 10/2005

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 05/2020 - 04/2007
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2016 - 10/2005
2	Phosphotransferases (Kinase)IBA 12/2007 - 04/2007
2	Tyrosine Kinase InhibitorsIBA 12/2007 - 10/2005
2	Tyrosine (L-Tyrosine)FDA Link 12/2007 - 04/2007
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2007 - 10/2005
2	Axitinib (AG 013736)IBA 04/2007 - 10/2005
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2021
1	Hematoxylin (Haematoxylon)IBA 10/2021
1	PK 11195 (PK11195)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Fibrinogen (Factor I)FDA Link 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2018
1	IceIBA 08/2012
1	GadoliniumIBA 07/2008
1	ErbB Receptors (EGF Receptor)IBA 12/2007
1	Growth Factor ReceptorsIBA 12/2007
1	Biological ProductsIBA 12/2007
1	Gefitinib (Iressa)FDA Link 12/2007

Therapy/Procedure

5	Therapeutics 01/2021 - 10/2005
1	Microspheres (Microsphere) 01/2018
1	Neoadjuvant Therapy 07/2008